Biotechnology company developing early liver diseases detection technology
COLUMBIA, Md., (August 19, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Pre-Seed Builder Fund investment in AGED Diagnostics. Housed under TEDCO’s Social Impact Funds, the Pre-Seed Builder Funds provide investment and support to Maryland-based technology companies led by founders from economically underserved backgrounds.
“TEDCO’s funding continues to support us in furthering our research and development for early liver disease detection,” said Rachel Zayas, CEO of AGED Diagnostics. “With this follow-on investment, we hope to move closer to our mission of providing access to early detection and intervention care for those with liver disease.”
AGED Diagnostics, based in Rockville, Md., is a biotechnology company developing an early detection and intervention solution for liver disease. Using genomic innovation, the company is working to create a more accurate blood test that could keep patients in a monitoring program, helping to reduce financial burdens and improve patient outcomes.
“AGED Diagnostics seeks to tackle both the health and financial aspects of liver disease through their detection technology,” said Jean-Luc Park, deputy chief investment officer & senior director of TEDCO’s Social Impact Funds. “At TEDCO, we work to support innovative companies like this who are working towards impactful solutions; through the Pre-Seed Builder Fund, we are honored to offer more than just funding in support for our portfolio companies.”
TEDCO’s Social Impact Funds are just one of the many investment opportunities available to qualifying technology-focused startups and small businesses across Maryland.
“As technologies continue to evolve, it is always promising to see innovation in biotechnology seek to support more efficient and affordable healthcare,” said TEDCO CEO, Troy LeMaile-Stovall. “Being ranked as a top state for health care, Maryland has a fertile ecosystem for entrepreneurs and companies looking to advance in the medical landscape.”
For more information, visit our page at www.tedcomd.com/funding.